Therapy of CIDP and related immune-mediated neuropathies

Neurology

Volumn 59, Issue 12 SUPPL. 6, 2002, Pages

  Koski, Carol Lee ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; BETA INTERFERON; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ANAPHYLAXIS; AUTOIMMUNITY; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; HEADACHE; HEMOLYSIS; HEPATITIS C; HUMAN; HYPEROSMOLARITY; IMMUNE MEDIATED INJURY; IMMUNOTHERAPY; KIDNEY TUBULE NECROSIS; MOTOR ACTIVITY; MYALGIA; NERVE CONDUCTION; NEUROPATHY; PERIPHERAL NERVE; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SENSORY GANGLION; TACHYCARDIA; THROMBOEMBOLISM;

EID: 0037168770     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.59.12_suppl_6.s22     Document Type: Review

References (46)

1. van Dijk GW, Notermans NC, Franssen H, Wokke JH. Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: A long-term follow-up study. J Neurol 1999;246:1134-1139.
2. Oh SJ, Joy JL, Kuruoglu R. Chronic sensory demyelinating neuropathy: Chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry 1992;55:677-680.
3. Dyck PJ, O'Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982;11:136-141.
4. Mehndiratta MM, Hughes RA. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2002(1):CD002062.
5. Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994;36:838-845.
6. Dyck PJ, Daube JR, O'Brien PC, et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986;314:461-465.
7. Hahn AF, Bolton CF, Pillay N, et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, crossover study. Brain 1996;119(pt 4):1055-1066.
8. Hahn AF, Bolton CF, Zochodne D, Feasby TE. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, crossover study. Brain 1996;119(pt 4):1067-1077.
9. Mendell JR, Barohn RJ, Freimer ML, et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001;56:445-449.
10. Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195-201.
11. Korinthenberg R. Chronic inflammatory demyelinating polyradiculoneuropathy in children and their response to treatment. Neuropediatrics 1999;30:190-196.
12. Nevo Y, Pestronk A, Kornberg AJ, et al. Childhood chronic inflammatory demyelinating neuropathies: Clinical course and long-term follow-up. Neurology 1996;47:98-102.
13. Nevo Y, Topaloglu H. Childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria). 88th ENMC International Workshop. Naarden, The Netherlands, December 8-10, 2000. Neuromusc Disord 2002;12:195-200.
14. Good JL, Chehrenama M, Mayer RF, Koski CL. Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy. Neurology 1998;51:1735-1738.
15. Mowzoon N, Sussman A, Bradley WG. Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory palyneuropathy and inclusion body myositis. J Neurol Sci 2001;185:119-122.
16. Ahlmen J, Andersen O, Hallgren G, Peilot B. Positive effects of tacrolimus in a case of CIDP. Transplant Proc 1998;30:4194. Abstract.
17. Gorson KC, Ropper AH, Clark BD, Dew RB III, Simovic D, Allam G. Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a. Neurology 1998;50:84-87.
18. Hadden RD, Sharrack B, Bensa S, Soudain SE, Hughes RA. Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1999;53:57-61.
19. Dyck PJ, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999;53:2113-2121.
20. van den Berg-Vos RM, van den Berg LH, Franssen H, et al. Multifocal inflammatory demyelinating neuropathy: A distinct clinical entity? Neurology 2000;54:26-32.
21. Amato AA, Barohn RJ. Diabetic Lumbosacral Polyradiculoneuropathies. 2001;3:139-146.
22. Romedenne P, Mukendi R, Stasse P, Indekeu P, Buysschaert M, Colin IM. An unusual neuropathy in a diabetic patient: Evidence for intravenous immunoglobulin-induced effective therapy. Diabetes Metab 2001;27(2 pt 1):155-158.
23. Baba M. Diabetic amyotrophy or proximal diabetic neuropathy an immune-mediated condition? Intern Med 2001;40:273-274.
24. Krendel DA, Zacharias A, Younger DS. Autoimmune diabetic neuropathy. Neurol Clin 1997;15:959-971.
25. Krendel DA, Costigan DA, Hopkins LC. Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 1995;52:1053-1061.
26. Ogawa T, Taguchi T, Tanaka Y, Ikeguchi K, Nakano I. Intravenous immunoglobulin therapy for diabetic amyotrophy. Intern Med 2001;40:349-352.
27. Suarez GA, Giannini C, Bosch EP, et al. Immune brachial plexus neuropathy: Suggestive evidence for an inflammatory-immune pathogenesis. Neurology 1996;46:559-561.
28. Nobile-Orazio E. Multifocal motor neuropathy. J Neuroimmunol 2001;115:4-18.
29. Azulay JP, Blin O, Pouget J, et al. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: A double-blind, placebo-controlled study. Neurology 1994;44(3 pt 1):429-432.
30. Federico P, Zochodne DW, Hahn AF, Brown WF, Feasby TE. Multifocal motor neuropathy improved by IVIg. Randomized, double-blind placebo-controlled, study. Neurology 2000;55:1256-1262.
31. Leger JM, Chassande B, Musset L, Meininger V, Bouche P, Baumann N. Intravenous immunoglobulin therapy in multifocal motor neuropathy: A double-blind, placebo-controlled study. Brain 2001;124(pt 1):145-153.
32. van den Berg LH, Kerkhoff H, Oey PL, et al. Treatment of multifocal motor neuropathy with high dose intravenous immuno-globulins: A double-blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1995;59:248-252.
33. Elliott JL, Pestronk A. Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin. Neurology 1994;44:967-968.
34. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-78.
35. Feldman EL, Bromberg MB, Albers JW, Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 1991;30:397-401.
36. Meucci N, Cappellari A, Barbieri S, Scarlato G, Nobile-Orazio E. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 1997;63:765-769.
37. Martina IS, van Doorn PA, Schmitz PI, Meulstee J, van der Meche FG. Chronic motor neuropathies: Response to interferon-beta1a after failure of conventional therapies. J Neurol Neurosurg Psychiatry 1999;66:197-201.
38. Gorson KC, Ropper AH, Weinberg DH, Weinstein R. Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy. Muscle Nerve 2001;24:778-786.
39. Dalakas MC, Quarles RH, Farrer RG, et al. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 1996;40:792-795.
40. Mariette X, Chastang C, Clavelou P, Louboutin JP, Leger JM, Brouet JC. A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group. J Neurol Neurosurg Psychiatry 1997;63:28-34.
41. Levine TD, Pestronk A. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab. Neurology 1999;52:1701-1704.
42. Griffin JW, Cornblath DR, Alexander E, et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol 1990;27:304-315.
43. Sobue G, Yasuda T, Kachi T, Sakakibara T, Mitsuma T. Chronic progressive sensory ataxic neuropathy: Clinicopathological features of idiopathic and Sjögren's syndrome-associated cases. J Neurol 1993;240:1-7.
44. Senties-Madrid H, Vega-Boada F. Paraneoplastic syndromes associated with anti-Hu antibodies. Isr Med Assoc J 2001;3:94-103.
45. Uchuya M, Graus F, Vega F, Rene R, Delattre JY. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 1996;60:388-392.
46. Laloux P, Brucher JM, Guerit JM, Sindic CJ, Laterre EC. Subacute sensory neuronopathy associated with Sjögren's sicca syndrome. J Neurol 1988;235:352-354.